Antioxidant peroxiredoxin 6 protein rescues toxicity due to oxidative stress and cellular hypoxia in vitro, and attenuates prion-related pathology in vivo
Antioxidant peroxiredoxin 6 protein rescues toxicity due to oxidative stress and cellular hypoxia in vitro, and attenuates prion-related pathology in vivo
Protein misfolding, mitochondrial dysfunction and oxidative stress are common pathomechanisms that underlie neurodegenerative diseases. In prion disease, central to these processes is the post-translational transformation of cellular prion protein (PrPc) to the aberrant conformationally altered isoform; PrPSc. This can trigger oxidative reactions and impair mitochondrial function by increasing levels of peroxynitrite, causing damage through formation of hydroxyl radicals or via nitration of tyrosine residues on proteins. The 6 member Peroxiredoxin (Prdx) family of redox proteins are thought to be critical protectors against oxidative stress via reduction of H2O2, hydroperoxides and peroxynitrite. In our in vitro studies cellular metabolism of SK-N-SH human neuroblastoma cells was significantly decreased in the presence of H2O2 (oxidative stressor) or CoCl2 (cellular hypoxia), but was rescued by treatment with exogenous Prdx6, suggesting that its protective action is in part mediated through a direct action. We also show that CoCl2-induced apoptosis was significantly decreased by treatment with exogenous Prdx6. We proposed a redox regulator role for Prdx6 in regulating and maintaining cellular homeostasis via its ability to control ROS levels that could otherwise accelerate the emergence of prion-related neuropathology. To confirm this, we established prion disease in mice with and without astrocyte-specific antioxidant protein Prdx6, and demonstrated that expression of Prdx6 protein in Prdx6 Tg ME7-animals reduced severity of the behavioural deficit, decreased neuropathology and increased survival time compared to Prdx6 KO ME7-animals. We conclude that antioxidant Prdx6 attenuates prion-related neuropathology, and propose that augmentation of endogenous Prdx6 protein represents an attractive adjunct therapeutic approach for neurodegenerative diseases.
neurodegeneration, prion, ME7, astrocytes, peroxiredoxin 6, antioxidant
1-14
Asuni, Ayodeji A.
b1412b1b-9794-4705-aada-aed5d3da038f
Guridi, Maitea
a9e5b9d5-8447-4124-a57c-f652e099a1c2
Sanchez, Sandrine
280cb177-57d0-4194-9742-24aaca487a42
Sadowski, Martin J.
8add36aa-b648-4378-91e3-94e85a19b977
Asuni, Ayodeji A.
b1412b1b-9794-4705-aada-aed5d3da038f
Guridi, Maitea
a9e5b9d5-8447-4124-a57c-f652e099a1c2
Sanchez, Sandrine
280cb177-57d0-4194-9742-24aaca487a42
Sadowski, Martin J.
8add36aa-b648-4378-91e3-94e85a19b977
Asuni, Ayodeji A., Guridi, Maitea, Sanchez, Sandrine and Sadowski, Martin J.
(2015)
Antioxidant peroxiredoxin 6 protein rescues toxicity due to oxidative stress and cellular hypoxia in vitro, and attenuates prion-related pathology in vivo.
Neurochemistry International, .
(doi:10.1016/j.neuint.2015.08.006).
(PMID:26265052)
Abstract
Protein misfolding, mitochondrial dysfunction and oxidative stress are common pathomechanisms that underlie neurodegenerative diseases. In prion disease, central to these processes is the post-translational transformation of cellular prion protein (PrPc) to the aberrant conformationally altered isoform; PrPSc. This can trigger oxidative reactions and impair mitochondrial function by increasing levels of peroxynitrite, causing damage through formation of hydroxyl radicals or via nitration of tyrosine residues on proteins. The 6 member Peroxiredoxin (Prdx) family of redox proteins are thought to be critical protectors against oxidative stress via reduction of H2O2, hydroperoxides and peroxynitrite. In our in vitro studies cellular metabolism of SK-N-SH human neuroblastoma cells was significantly decreased in the presence of H2O2 (oxidative stressor) or CoCl2 (cellular hypoxia), but was rescued by treatment with exogenous Prdx6, suggesting that its protective action is in part mediated through a direct action. We also show that CoCl2-induced apoptosis was significantly decreased by treatment with exogenous Prdx6. We proposed a redox regulator role for Prdx6 in regulating and maintaining cellular homeostasis via its ability to control ROS levels that could otherwise accelerate the emergence of prion-related neuropathology. To confirm this, we established prion disease in mice with and without astrocyte-specific antioxidant protein Prdx6, and demonstrated that expression of Prdx6 protein in Prdx6 Tg ME7-animals reduced severity of the behavioural deficit, decreased neuropathology and increased survival time compared to Prdx6 KO ME7-animals. We conclude that antioxidant Prdx6 attenuates prion-related neuropathology, and propose that augmentation of endogenous Prdx6 protein represents an attractive adjunct therapeutic approach for neurodegenerative diseases.
Text
Asuni_Antioxidant.pdf
- Accepted Manuscript
More information
Accepted/In Press date: 6 August 2015
e-pub ahead of print date: 8 August 2015
Keywords:
neurodegeneration, prion, ME7, astrocytes, peroxiredoxin 6, antioxidant
Organisations:
Centre for Biological Sciences
Identifiers
Local EPrints ID: 383006
URI: http://eprints.soton.ac.uk/id/eprint/383006
ISSN: 0197-0186
PURE UUID: eeaeee22-c4b7-42ae-9283-ddbced23f7e9
Catalogue record
Date deposited: 21 Oct 2015 10:42
Last modified: 14 Mar 2024 21:36
Export record
Altmetrics
Contributors
Author:
Ayodeji A. Asuni
Author:
Maitea Guridi
Author:
Sandrine Sanchez
Author:
Martin J. Sadowski
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics